These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19776093)

  • 21. Combined medication of lovastatin with rolipram suppresses severity of experimental autoimmune encephalomyelitis.
    Paintlia AS; Paintlia MK; Singh I; Singh AK
    Exp Neurol; 2008 Dec; 214(2):168-80. PubMed ID: 18775426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rolipram suppresses experimental autoimmune neuritis and prevents relapses in Lewis rats.
    Zou LP; Deretzi G; Pelidou SH; Levi M; Wahren B; Quiding C; van der Meide P; Zhu J
    Neuropharmacology; 2000 Jan; 39(2):324-33. PubMed ID: 10670428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitigation of stress-induced gastric mucosal lesions by a specific type IV phosphodiesterase inhibitor.
    Kato S; Otaka M; Odashima M; Sato T; Jin M; Matsuhashi T; Konishi N; Watanabe S
    Dig Dis Sci; 2007 Mar; 52(3):711-6. PubMed ID: 17253136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis.
    McCann FE; Palfreeman AC; Andrews M; Perocheau DP; Inglis JJ; Schafer P; Feldmann M; Williams RO; Brennan FM
    Arthritis Res Ther; 2010; 12(3):R107. PubMed ID: 20525198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor.
    Genain CP; Roberts T; Davis RL; Nguyen MH; Uccelli A; Faulds D; Li Y; Hedgpeth J; Hauser SL
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3601-5. PubMed ID: 7536938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphodiesterase 4-targeted treatments for autoimmune diseases.
    Kumar N; Goldminz AM; Kim N; Gottlieb AB
    BMC Med; 2013 Apr; 11():96. PubMed ID: 23557064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of vesnarinone on TNF alpha production in human peripheral blood mononuclear cells and microglia: a preclinical study for the treatment of multiple sclerosis.
    Jiang H; Bielekova B; Okazaki H; Clarence-Smith K; Johnson KP; Bergey G; Martin R; Dhib-Jalbut S
    J Neuroimmunol; 1999 Jun; 97(1-2):134-45. PubMed ID: 10408967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific type IV phosphodiesterase inhibitor ameliorates thioacetamide-induced liver injury in rats.
    Matsuhashi T; Otaka M; Odashima M; Jin M; Komatsu K; Konishi N; Wada I; Sato T; Horikawa Y; Ohba R; Oyake J; Hatakeyama N; Watanabe S
    J Gastroenterol Hepatol; 2005 Jan; 20(1):135-40. PubMed ID: 15610458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type IV phosphodiesterase inhibitor is effective in prevention and treatment of experimental crescentic glomerulonephritis.
    Tam FW; Smith J; Agarwal S; Karkar AM; Morel D; Thompson EM; Pusey CD
    Nephron; 2000 Jan; 84(1):58-66. PubMed ID: 10644909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preventive effect of rolipram, a phosphodiesterase 4 enzyme inhibitor, on oxidative renal injury in acute ascending pyelonephritis model in rats.
    Görür S; Celik S; Hakverdi S; Aslantaş O; Erdoğan S; Aydin M; Ocak S; Namik Kiper A
    Urology; 2008 Oct; 72(4):743-8. PubMed ID: 18554698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the phosphodiestrase-4 inhibitor rolipram on lung resistance and inflammatory reaction in experimental asthma.
    Nejman-Gryz P; Grubek-Jaworska H; Glapiński J; Hoser G; Chazan R
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 4():229-39. PubMed ID: 17072051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathophysiological effects of intravenous phosphodiesterase type 4 inhibitor in addition to surfactant lavage in meconium-injured newborn piglet lungs.
    Chen WY; Lin CH; Lee YS; Tsao PC; Jeng MJ
    Pediatr Pulmonol; 2020 Sep; 55(9):2272-2282. PubMed ID: 32478966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphodiesterase type IV inhibitors in the treatment of multiple sclerosis.
    Dinter H; Onuffer J; Faulds D; Perez HD
    J Mol Med (Berl); 1997 Feb; 75(2):95-102. PubMed ID: 9083927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and ex vivo effects of the phosphodiesterase 4 inhibitor, rolipram, on thromboxane production in equine blood.
    Rickards KJ; Page CP; Lees P; Gettinby G; Cunningham FM
    J Vet Pharmacol Ther; 2003 Apr; 26(2):123-30. PubMed ID: 12667182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local delivery of rolipram, a phosphodiesterase-4-specific inhibitor, augments bone morphogenetic protein-induced bone formation.
    Tokuhara Y; Wakitani S; Imai Y; Nomura C; Hoshino M; Yano K; Taguchi S; Kim M; Kadoya Y; Takaoka K
    J Bone Miner Metab; 2010; 28(1):17-24. PubMed ID: 19554392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphodiesterase inhibitors reduce bronchial hyperreactivity and airway inflammation in unrestrained guinea pigs.
    Santing RE; Olymulder CG; Van der Molen K; Meurs H; Zaagsma J
    Eur J Pharmacol; 1995 Feb; 275(1):75-82. PubMed ID: 7774665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective inhibition of phosphodiesterase-4 ameliorates chronic colitis and prevents intestinal fibrosis.
    Videla S; Vilaseca J; Medina C; Mourelle M; Guarner F; Salas A; Malagelada JR
    J Pharmacol Exp Ther; 2006 Feb; 316(2):940-5. PubMed ID: 16254133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington's disease.
    Giampà C; Middei S; Patassini S; Borreca A; Marullo F; Laurenti D; Bernardi G; Ammassari-Teule M; Fusco FR
    Eur J Neurosci; 2009 Mar; 29(5):902-10. PubMed ID: 19291221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rolipram attenuates bleomycin A5-induced pulmonary fibrosis in rats.
    Pan JB; Hou YH; Zhang GJ
    Respirology; 2009 Sep; 14(7):975-82. PubMed ID: 19740258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.